Hermawan, A., & Putri, H. (2022). Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy. Springer.
Chicago Style CitationHermawan, Adam, and Herwandhani Putri. Bioinformatics Analysis Reveals the Potential Target of Rosiglitazone As an Antiangiogenic Agent for Breast Cancer Therapy. Springer, 2022.
MLA CitationHermawan, Adam, and Herwandhani Putri. Bioinformatics Analysis Reveals the Potential Target of Rosiglitazone As an Antiangiogenic Agent for Breast Cancer Therapy. Springer, 2022.
Warning: These citations may not always be 100% accurate.